Aquestive Therapeutics Inc. (AQST), which is developing the first and only non-device based, oral epinephrine product candidate for anaphylaxis, has a clinical trial catalyst to watch this quarter.
Anaphylaxis is a severe and rapidly occurring systemic hypersensitivity reaction that can be life-threatening. Primary triggers for reactions leading to anaphylaxis often involve medications, specific foods (such as peanuts), and insect sting venom.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.